Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Sep 2025
As of Sep 30, 2025
Jun 2025
As of Jun 30, 2025
ASSETS
Current assets:
Cash and cash equivalents
Restricted cash
Accounts receivable
Amount due from related parties
Inventories
Deposits, prepayments and other receivables
Total current assets
Non-current assets:
Plant and equipment, net
Intangible assets
Right-of-use assets
Deferred tax asset
Total non-current assets
TOTAL ASSETS
LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)
Current liabilities:
Accounts payable
Accrued liabilities and other payables
Contract liabilities
Amounts due to related parties
Loan
Lease liabilities – operating leases
Total current liabilities
Non-current liabilities:
Lease liabilities – operating leases
Other payables
Total non-current liabilities
TOTAL LIABILITIES
SHAREHOLDERS’ EQUITY (DEFICIT)
Treasury stock
Series X Super Voting Preferred Stock, $0.0001 par value, 75,000 shares designated; 75,000 and 0 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively
Common stock, par value US$0.0001, 200,000,000 shares authorized, 19,379,168 and 14,000,000 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Total equity attributable to Nusatrip Incorporated
Non-controlling interest
TOTAL EQUITY (DEFICIT)
TOTAL LIABILITIES AND EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support